Safety of thoracic radiotherapy after PD‐(L)1 inhibitor treatment in patients with lung cancer
Abstract Background The safety of thoracic radiotherapy (TRT) after programmed death 1/programmed death ligand 1 (PD‐(L)1) inhibitor treatment in patients with lung cancer was scarcely reported. This retrospective study was conducted to evaluate the incidence, severity, and risk factors of symptomat...
Salvato in:
| Autori principali: | , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wiley
2021-12-01
|
| Serie: | Cancer Medicine |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1002/cam4.4363 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|